» Articles » PMID: 34017943

Insights into the Endoscopic Management of Esophageal Achalasia

Overview
Publisher Sage Publications
Date 2021 May 21
PMID 34017943
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Achalasia is a primary esophageal motility disorder characterized by the loss of inhibitory neurons in the myenteric plexus, resulting in impaired relaxation of the esophagogastric junction. Achalasia is an incurable disease, and the treatment modalities are aimed at disruption of the esophagogastric junction and vary widely from pharmacological to endoscopic to surgical. Traditional endoscopic therapy includes pneumatic dilation, botulinum toxin injection, and peroral endoscopic myotomy. This review aims to provide an overview of the endoscopic management of achalasia, while focusing on the utilization of peroral endoscopic myotomy and other novel approaches.

Citing Articles

Evaluating the Non-conventional Achalasia Treatment Modalities.

Tustumi F Front Med (Lausanne). 2022; 9:941464.

PMID: 35814742 PMC: 9263126. DOI: 10.3389/fmed.2022.941464.

References
1.
Inoue H, Shiwaku H, Kobayashi Y, Chiu P, Hawes R, Neuhaus H . Statement for gastroesophageal reflux disease after peroral endoscopic myotomy from an international multicenter experience. Esophagus. 2019; 17(1):3-10. PMC: 6976544. DOI: 10.1007/s10388-019-00689-6. View

2.
Eckardt V, Gockel I, Bernhard G . Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut. 2004; 53(5):629-33. PMC: 1774039. DOI: 10.1136/gut.2003.029298. View

3.
Teitelbaum E, Soper N, Pandolfino J, Kahrilas P, Hirano I, Boris L . Esophagogastric junction distensibility measurements during Heller myotomy and POEM for achalasia predict postoperative symptomatic outcomes. Surg Endosc. 2014; 29(3):522-8. PMC: 4343529. DOI: 10.1007/s00464-014-3733-1. View

4.
Annese V, Bassotti G, Coccia G, Dinelli M, DOnofrio V, Gatto G . A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut. 2000; 46(5):597-600. PMC: 1727941. DOI: 10.1136/gut.46.5.597. View

5.
Urakami S, Abe H, Tanaka S, Kawara F, Toyonaga T, Ariyoshi R . Development of a preoperative risk-scoring system for predicting poor responders to peroral endoscopic myotomy. Gastrointest Endosc. 2020; 93(2):398-405. DOI: 10.1016/j.gie.2020.06.028. View